The neuro-incretin concept

Regulatory Peptides

Volumn 194-195, Issue , 2014, Pages 3-5

  Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GASTRIC INHIBITORY POLYPEPTIDE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCAGON LIKE PEPTIDE 1; INCRETIN; NEUROTRANSMITTER;

AUTONOMIC NERVE; CONNECTOME; EDITORIAL; EFFERENT NERVE; GANGLION; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; INSULIN RELEASE; INTESTINE; NERVE ENDING; NERVE STIMULATION; NONHUMAN; PANCREAS ISLET; REATIC GANGLIA; VESTIBULAR SYSTEM; AUTONOMIC NERVOUS SYSTEM; METABOLISM;

AUTONOMIC NERVOUS SYSTEM; HUMANS; INCRETINS;

EID: 84921368289     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2014.09.003     Document Type: Editorial

References (35)

1. Ahrén B. Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 2000, 43:393-410.
2. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
3. Nishizawa M., Nakabayashi H., Uehara K., Nakagawa A., Uchida K., Koya D. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways. Am J Physiol Endocrinol Metab 2013, 305:E376-E387.
4. Ahrén B., Holst J.J. The cephalic insulin response to meal ingestion in humans is dependent both on cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 2001, 50:1030-1038.
5. Rossi J., Santamäki P., Airaksinen M.S., Herzig K.H. Parasympathetic innervation and function of endocrine pancreas requires the glial cell line-derived factor family receptor alpha2 (GFRalpha2). Diabetes 2005, 54:1324-1330.
6. Ahrén B. Neuropeptides and islet hormone secretion. International textbook of diabetes mellitus 2014, Wiley-Blackwell, Oxford, [in press]. 4th ed. R. DeFronzo, E. Ferrannini, K.G.M.M. Alberti, Zimmet (Eds.).
7. Berthoud H.R., Bereiter D.A., Trimble E.R., Siegel E.G., Jeanrenaud B. Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization. Diabetologia 1981, 20 Suppl.:393-401.
8. La Barre J. Sur les possibilite's d'un traitement du diabète par l'incrétine. Bull Acad R Med Belg 1932, 12:620-634.
9. D'Alessio D.A., Kieffer T.J., Taborsky G.J., Havel P.J. Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clin Endocrinol Metab 2001, 86:1253-1259.
10. McIntyre N., Holdsworth C.D., Turner R.S. New interpretation of oral glucose tolerance. Lancet 1964, 2:20-21.
11. Elrick H., Stimmler L., Hlad C.J., Arai Y. Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 1964, 24:1076-1082.
12. Perley M.J., Kipnis D.M. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 1967, 46:1954-1962.
13. Nauck M., Stöckmann F., Ebert R., Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 1986, 29:46-52.
14. Lindgren O., Carr R.D., Deacon C.F., Holst J.J., Pacini G., Mari A., et al. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans. J Clin Endocrinol Metab 2011, 96:2519-2524.
15. Ahrén B., Holst J.J., Deacon C.F. An incretin effect exists after amino acids administration in humans: effects on incretin hormones and insulin after oral vs. intravenous amino acids. Diabetes 2014, 63(Suppl. 1):A50.
16. Deacon C.F. What do we know about the secretion and degradation of incretin hormones?. Regul Pept 2005, 128:117-124.
17. Chandarana K., Gelegen C., Irvine E.E., Choudhury A.I., Amouyal C., Andreeli F., et al. Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance. Mol Metab 2013, 2:142-152.
18. Vilsbøll T., Krarup T., Madsbad S., Holst J.J. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 2003, 114:115-121.
19. Rocca A.S., Brubaker P.L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999, 140:1687-1694.
20. Greenberg G.R., Pokol-Daniel S. Neural modulation of glucose-dependent insulinotropic peptide (GIP) and insulin secretion in conscious dogs. Pancreas 1994, 9:531-535.
21. Balkan B., Liu X. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanism. Am J Physiol Regul Integr Comp Physiol 2000, 279:R1449-R1454.
22. Ahrén B. Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice. Am J Physiol Regul Integr Comp Physiol 2004, 286:R269-R271.
23. Vahl T.P., Tauchi M., Durler T.S., et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007, 147:4965-4973.
24. Plamboeck A., Veedfald S., Deacon C.F., Hartmann B., Wettergren A., Svendsen L.B., et al. Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty. Eur J Endocrinol 2013, 169:187-201.
25. AhlkvistL Ahrén B. Inhibiting the cholinergic effector system of the vagus nerve reduces the insulinotropic effects of both GLP-1 and GIP. Diabetologia 2014, 57. Suppl.:1.
26. Nishizawa M., Nakabayashi H., Uchida K., Nakagawa A., Niijima A. The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. J Auton Nerv Syst 1996, 61:149-154.
27. Gaisano G.G., Park S.J., Daly D.M., Beyak M.J. Glucagon-like peptide-1 inhibits voltage-gated potassium currents in mouse nodose ganglion neurons. Neurogastroenterol Motil 2010, 22:470-479.
28. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol 1996, 271:E808-E813.
29. Fujiwara K., Gotoh K., Chiba S., Masaki T., Katsuragi I., Kakuma T., et al. Intraportal administration of DPP-IV inhibitor regulates insulin secretion and food intake mediated by the hepatic vagal afferent nerve in rats. J Neurochem 2012, 121:66-76.
30. Labouesse M.A., Stadlbauer U., Weber E., Arnold M., Langhans W., Pacheco-López G. Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4. J Neuroendocrinol 2012, 24:1505-1516.
31. Knauf C., Cani P.D., Perrin C., Iglesias M.A., Maury J.F., Bernard E., et al. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 2005, 115:3554-3563.
32. Babic T., Browning K.N., Kawaguchi Y., Tang X., Travagli R.A. Pancreatic insulin and exocrine secretion are under the modulatory control of distinct subpopulations of vagal motoneurones in the rat. J Physiol 2012, 590:3611-3622.
33. Mussa B.M., Verberne A.J. The dorsal motor nucleus of the vagus and regulation of pancreatic secretory function. Exp Physiol 2013, 98:25-37.
34. Wan S., Coleman F.H., Travagli R.A. Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1474-G1482.
35. Kirchgessner A.L., Gershon M.D. Innervation and regulation of the pancreas by neurons in the gut. Z Gastroenterol Verh 1991, 26:230-233.